XML 50 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Employee Benefit Plans (Tables)
6 Months Ended
Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Option Activity

The following is a summary of stock option activity for the current year period:

 

 

Stock Options

 

 

Number of

Shares

 

Weighted Average

Exercise Price

 

Aggregate

Intrinsic Value

(in thousands)

 

Weighted Average

Remaining

Contractual Term

(in years)

 

Outstanding at December 31, 2020

 

15,100,142

 

$

16.07

 

$

143,156

 

 

6.9

 

Granted

 

2,636,878

 

$

21.77

 

 

 

 

 

 

 

Exercised

 

(1,229,180

)

$

14.45

 

 

 

 

 

 

 

Forfeited

 

(774,324

)

$

19.35

 

 

 

 

 

 

 

Expired

 

(81,383

)

$

19.49

 

 

 

 

 

 

 

Outstanding, vested and expected to vest at June 30, 2021

 

15,652,133

 

$

16.98

 

$

67,395

 

 

6.8

 

Vested and exercisable at June 30, 2021

 

10,668,302

 

$

15.68

 

$

58,283

 

 

5.9

 

Summary of Estimated Fair Value of Stock Options Granted Using Weighted-average Assumptions

Except for the Executive Option Grant discussed above, the Company used the Black-Scholes-Merton option pricing model to estimate the fair value of stock options granted using the following weighted-average assumptions:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2021

 

2020

 

2021

 

2020

Expected life (in years)

 

6.2

 

6.2

 

5.8

 

5.8

Risk-free interest rate

 

1.2%

 

0.5%

 

0.8%

 

1.4%

Volatility

 

51%

 

52%

 

51%

 

48%

Dividend yield

 

—%

 

—%

 

—%

 

—%

Fair value of common stock

 

$18.39

 

$19.24

 

$21.70

 

$21.15

 

Summary of Estimated Fair Value of ESPP Purchase Rights Granted Using Weighted-average Assumptions

The Company used the Black-Scholes-Merton option pricing model to estimate the fair value of ESPP purchase rights granted using the following weighted-average assumptions:

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2021

 

2020

 

2021

 

2020

Expected life (in years)

 

1.3

 

1.3

 

1.3

 

1.3

Risk-free interest rate

 

0.1%

 

0.2%

 

0.1%

 

0.2%

Volatility

 

53%

 

58%

 

53%

 

58%

Dividend yield

 

—%

 

—%

 

—%

 

—%

Fair value of common stock

 

$19.12

 

$19.81

 

$19.12

 

$19.81

Summary of Stock-based Compensation Expense Recognized in Financial Statements

Stock-based compensation expense recognized in the condensed consolidated financial statements is as follows:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

(in thousands)

 

2021

 

2020

 

2021

 

2020

 

Cost of revenue

 

$

1,580

 

$

1,047

 

$

3,062

 

$

2,007

 

Research and development

 

 

10,313

 

 

7,496

 

 

19,810

 

 

13,953

 

Sales and marketing

 

 

6,414

 

 

4,841

 

 

12,192

 

 

9,184

 

General and administrative

 

 

7,266

 

 

6,087

 

 

14,108

 

 

11,829

 

Stock-based compensation expense, net of amounts capitalized

 

 

25,573

 

 

19,471

 

 

49,172

 

 

36,973

 

Capitalized stock-based compensation expense

 

 

577

 

 

710

 

 

1,136

 

 

1,486

 

Stock-based compensation expense

 

$

26,150

 

$

20,181

 

$

50,308

 

$

38,459

 

Summary of Unamortized Stock-based Compensation

 

As of June 30, 2021, unamortized stock-based compensation was as follows:

 

 

Unrecognized

stock-based

compensation

(in thousands)

 

Weighted

average

vesting

period

(in years)

 

Restricted stock units

$

140,150

 

 

2.4

 

Stock options

 

41,763

 

 

2.3

 

Restricted stock awards

 

5,872

 

 

2.3

 

ESPP

 

7,127

 

 

1.9

 

Total unrecognized stock-based compensation

$

194,912

 

 

 

 

 

Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Restricted Stock Units and Restricted Stock Awards

The following is a summary of restricted stock units for the current year period:

 

 

Restricted Stock Units

 

 

Number of

Shares

 

Weighted Average

Grant-Date

Fair Value

 

Weighted Average

Remaining

Contractual Term

(in years)

 

Unvested at December 31, 2020

 

7,000,855

 

$

17.72

 

 

1.1

 

Granted

 

3,279,068

 

$

25.56

 

 

 

 

Vested

 

(1,993,215

)

$

17.83

 

 

 

 

Forfeited/cancelled

 

(981,563

)

$

19.84

 

 

 

 

Unvested at June 30, 2021

 

7,305,145

 

$

20.93

 

 

1.2

 

Restricted Stock Awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Restricted Stock Units and Restricted Stock Awards

The following is a summary of restricted stock awards for the current year period:

 

 

Restricted Stock Awards

 

 

Number of

Shares

 

Weighted Average

Grant-Date

Fair Value

 

Weighted Average

Remaining

Contractual Term

(in years)

 

Unvested at December 31, 2020

 

102,460

 

$

18.30

 

 

1.2

 

Granted

 

274,417

 

$

26.89

 

 

 

 

Vested

 

(51,619

)

$

21.21

 

 

 

 

Forfeited/cancelled

 

(64,823

)

$

26.89

 

 

 

 

Unvested at June 30, 2021

 

260,435

 

$

24.64

 

 

2.1